Beigene, Ltd. (NASDAQ:ONC) SVP Sells $310,164.08 in Stock

Beigene, Ltd. (NASDAQ:ONC) SVP Chan Henry Lee sold 1,202 shares of Beigene stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $258.04, for a total value of $310,164.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Beigene Stock Performance

Shares of Beigene stock opened at $278.38 on Friday. The stock has a market cap of $27.24 billion, a P/E ratio of -33.78, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a one year low of $126.97 and a one year high of $287.88. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93.

Beigene (NASDAQ:ONC) last released its quarterly earnings data on Thursday, February 27th. The company reported ($1.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.55). Beigene had a negative return on equity of 25.12% and a negative net margin of 25.94%. Analysts expect that Beigene, Ltd. will post -5.82 EPS for the current fiscal year.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.